Join to View Full Profile
20 York StYale-New Haven Children's Hospital-Ep 2608New Haven, CT 06510
Phone+1 203-785-3624
Fax+1 203-785-7037
Dr. Bifulco is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Memorial Sloan Kettering Cancer Center Oncologic PathologyFellowship, Selective Pathology, 1998 - 2000
Yale-New Haven Medical CenterResidency, Pathology-Anatomic and Clinical, 1996 - 1997
Griffin HospitalInternship, Internal Medicine, 1995 - 1996
University of Milan Faculty of MedicineClass of 1994
Certifications & Licensure
OR State Medical License 2008 - 2025
American Board of Pathology Anatomic Pathology- American Board of Pathology Molecular Genetic Pathology
Publications & Presentations
PubMed
- Improving immunotherapy responses by dual inhibition of macrophage migration inhibitory factor and PD-1.Thuy T Tran, Gabriela Athziri Sánchez-Zuno, Lais Osmani, Jasmine Caulfield, Caroline Naomi Valdez
JCI Insight. 2025-10-22 - 1 citationsSITC perspective: leveraging patient enrichment biomarkers to accelerate early phase IO drug development.Leisha A Emens, Christine Moussion, Patrick Hwu, James L Gulley, Pamela S Ohashi
Journal for Immunotherapy of Cancer. 2025-06-22 - 11 citationsSociety for Immunotherapy of Cancer (SITC) consensus statement on essential biomarkers for immunotherapy clinical protocols.Tricia R Cottrell, Michael T Lotze, Alaa Ali, Carlo B Bifulco, Christian M Capitini
Journal for Immunotherapy of Cancer. 2025-03-07
Press Mentions
Comprehensive Genomic Profiling at Diagnosis Extends Survival in Patients with Advanced CancerNovember 13th, 2024- Blood Tests That Can Detect Cancer Are About to Hit the Market. But Experts Are Still Waiting to See if They Can Upend Deadly DiseaseOctober 20th, 2021
- Providence Molecular Genomics Lab Utilizes Illumina Technology to Offer Genomics for AllAugust 18th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
